
Japan · Chemicals startup
With our unique Blockmer-based oligonucleotide synthesis technology, we offer extremely high purity oligonucleotides in mg to ton scale at reasonable prices.
Funding reportedLast round: Venture (Round not Specified)
With our unique Blockmer-based oligonucleotide synthesis technology, we offer extremely high purity oligonucleotides in mg to ton scale at reasonable prices.
・Oligonucleotide Synthesis Service ・BlockmerTM intermediates Sales ・Nucleotide analog synthesis Service ・mRNA production solution Service *NOTICE Our official website is currently undergoing maintenance. In the meantime, please refer to our company brochure and contact us via the links below: ■Company Brochure (Google Drive): https://drive.google.com/drive/folders/1NrEThFZTfB4FT-y45U8-EvDmOvmtdztI?usp=drive_link ■Inquiry Form (Google Form): https://forms.gle/Sjd5Cb2yCA1Xh7YaA We apologize for any inconvenience.
Funding, as reported
What they build
Known for
health careapimodified nucleotidesmolecular diagnosticscpg odn d35class b cpg odnsbiotech chemicalstlr9 agonistsdistributionmanufacturingimmune response modulationmodified rnadna research suppliesapi servicespharmaceuticaldna synthesis
Built with from their website
WordPress.orgSakura InternetGoogle WorkspaceViewport MetaGoogle MeetPriority HintsMySQLPrimeNGMobile FriendlyRSS
WordpressNginxPHPGoogle Search ConsoleGmail
Add your raise, your deck and your story, and put NATiAS Inc. in front of investors. Or tell us what we have wrong.